Related references
Note: Only part of the references are listed.Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety
Andrea Rossi
International Journal of Chronic Obstructive Pulmonary Disease (2016)
Minimal Clinically Important Differences in Pharmacological Trials
Paul W. Jones et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients
Francesco Blasi et al.
PLOS ONE (2014)
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Jadwiga A. Wedzicha et al.
RESPIRATORY MEDICINE (2014)
Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
Kohei Hasegawa et al.
RESPIRATORY RESEARCH (2014)
Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?
Frits M. E. Franssen et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study
Eric D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
J. F. Donohue et al.
RESPIRATORY MEDICINE (2013)
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
Jadwiga A. Wedzicha et al.
LANCET RESPIRATORY MEDICINE (2013)
Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting
Marc Miravitlles et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2013)
Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease A Review of the Evidence and Methodological Issues
Maureen P. M. H. Rutten-van Molken et al.
PHARMACOECONOMICS (2012)
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
O. Kornmann et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD
Andrew P. Yu et al.
RESPIRATORY MEDICINE (2011)
Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis
Andrew P. Yu et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review
Marie Westwood et al.
RESPIRATORY RESEARCH (2011)
Cardiovascular Safety of QVA149, a Combination of Indacaterol and NVA237, in COPD Patients
Boudewijn Van de Maele et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2010)
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms
J. A. van Noord et al.
RESPIRATORY MEDICINE (2010)
The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease
Jan A. van Noord et al.
THORAX (2010)
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
Claus Vogelmeier et al.
RESPIRATORY RESEARCH (2010)
Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD
D. P. Tashkin et al.
RESPIRATORY MEDICINE (2009)
A graphical approach to sequentially rejective multiple test procedures
Frank Bretz et al.
STATISTICS IN MEDICINE (2009)
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
Claus Vogelmeier et al.
RESPIRATORY MEDICINE (2008)
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
JA van Noord et al.
CHEST (2006)
Patterns of comorbidities in newly diagnosed COPD and asthma in primary care
JB Soriano et al.
CHEST (2005)
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
JA van Noord et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Cognitive performance in patients with COPD
JJW Liesker et al.
RESPIRATORY MEDICINE (2004)
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
PW Jones
EUROPEAN RESPIRATORY JOURNAL (2002)
Share Paper
